5
Participants
Start Date
March 31, 2009
Primary Completion Date
August 31, 2010
Study Completion Date
December 31, 2011
Carboplatin
Intravenous (IV) on Day 1 of each 21-day cycle, as per dose escalation schedule (dose levels 1 and 2: dose levels 3 and 4). Number of cycles: 6 maximum.
Etoposide
80mg/m2, Intravenous on Days 1, 2, 3 of a 21-day cycle (all dose levels). Number of cycles: 6 maximum.
RAD001
Orally on Days 1-21 of a 21-day cycle, as per dose escalation schedule (dose level 1: 2.5 mg, dose level 2: 5 mg, dose level 3: 5.0 mg, and dose level 4: 10.0 mg). Number of cycles: unlimited (drug taken from Day 1 until progression of disease or unacceptable toxicity).
University of California Davis Cancer Center, Sacramento
Collaborators (1)
Novartis
INDUSTRY
University of California, Davis
OTHER